Long-Term Clinical Course and Histopathologic Scoring in Acute Crescentic Glomerulonephritis

References

• Couser W G. Idiopathic rapidly progressive glomerulonephritis. Am J Nephrol 1982; 2: 57–69
   PubMed Web of Science ®Google Scholar
• Couser W G, Abrass C K. Pathogenesis of membranous nephropathy. Annu Rev Med 1988; 39: 517–530
   PubMedGoogle Scholar
• Igelmann H-J, Intorp H W, Gruber H, Losse H. Die Bedeutung zellulaˇrer Immunreaktion bei den rapid progressiven Glomerulonephritiden. Verh Dtsch Ges Inn Med 1978; 13: 3–7
   Google Scholar
• Bacani R A, Velasquez F, Kanter A, Pirani C, Pollak V E. Rapidly progressive (non-streptoccocal) glomerulonephritis. Ann Intern Med 1986; 69: 463–485
   Google Scholar
• Stahl R AK. Therapie der rasch progressiven Glomerulonephritis. Dtsch Med Wschr 1991; 116: 1799–1803
   PubMedGoogle Scholar
• Stoffner D, Samtleben W, Gurland H J. Verbesserung der Prognose der rapid progressiven Glomerulonephritis durch Plasmapheresebehandlung. Lebensversicherungsmedizin 1985; 3: 63–65
   Google Scholar
• Couser W G. Rapidly progressive glomerulonephritis: classifications, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988; 11: 449–464
   PubMed Web of Science ®Google Scholar
• Groene H J, Osborn M, Gross W L. Die entzündlichen Gefäserkrankungen der Niere. Verh Dtsch Ges Pathol 1989; 73: 181–192
   PubMedGoogle Scholar
• Thoenes W. Pathologie der Glomerulonephritiden. Internist 1989; 30: 127–139
   PubMedGoogle Scholar
• Austin H A, Muenz L R, Joyce K M, Antonobych T A. Prognostic factors in lupus nephritis. Am J Med 1983; 75: 382–391
   PubMed Web of Science ®Google Scholar
• Cassidy M JD, Gaskin G, Savill J, Pusey C D, Rees A J. Towards a more rapidly diagnosis of rapidly progressive glomerulonephritis. Br Med J 1990; 301: 329–331
   PubMedGoogle Scholar
• Müller G A, Seipel L, Risler T. Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosupression. Klin Wschr 1986; 64: 231–238
   PubMedGoogle Scholar
• Nässberger L, Sjöholm A G, Bygren P, Thysell H. Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation. J Intern Med 1989; 225: 191–196
   PubMed Web of Science ®Google Scholar
• Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s—is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?. J R Coll Physicians Lond 1990; 24: 284–288
   PubMedGoogle Scholar
• Frasca G M, Zoumparidis N G, Borgnino L C, Neri L, Vangelista A, Bonimini V. Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis—clinical course and long-term outcome. Int J Artif Org 1993; 16: 11–19
   PubMedGoogle Scholar
• Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1–12
   PubMed Web of Science ®Google Scholar
• Andrassy K, Waldherr R. Systemerkrankungen mit Nierenbeteiligung. Dtsch Ärztebl 1991; 88(6)B-266–272
   Google Scholar
• Berlyne G J, Baker S B. Acute anuric glomerulonephritis. Q J Med 1964; 57: 105–111
   Google Scholar
• Cameron J S. Die Behandlung der extrakapillär-proliferierenden Glomerulonephritis. Dtsch Med Wschr 1988; 46: 1812–1820
   Google Scholar
• Gross W L. Neue Aspekte bei der Wegenerschen Granulomatose. Dtsch Ärzteblatt 1991; 88: B-28–34
   Google Scholar
• Cohen-Tervaert J W, Mulder L, Stegemann C, Elema J, Huitema M, The H, Kallenberg C G. Occurrence of autoantibodies to human leukocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52: 115–120
   PubMedGoogle Scholar
• Florine C W, Dwyer M, Holland E J. Wegener's granulomatosis presenting with sclerokeratitis diagnosed by antineutrophil cytoplasmic antibodies (ANCA). Surv Ophthalmol 1993; 37: 373–376
   PubMedGoogle Scholar
• Gross W L, Schmitt W H, Csernok E. Antineutrophil cytopasmatic antibody-associated diseases: a rheumatologist's perspective. Am J Kid Dis 1991; 18: 175–179
   PubMedGoogle Scholar
• Röckel A, Romen W, Heidland A. Neue Aspekte in der Therapie der rapid progressiven Glomerulonephritis. Dtsch Med Wschr 1982; 107: 1580
   Google Scholar
• Rosenblatt S T, Knight W, Bannayan G A, Wilson C B, Stein J H. Treatment of Goodpasture's syndrom with plasampheresis: a case report and review of literature. Am J Med 1979; 66: 689
   PubMedGoogle Scholar
• Bach D, Heering P, Helmchen U, Gross W-L, Grabensee B. Rapid-progressive Glomerulonephritis Typ III mit Nachweis von anti-cytoplasmatischen Antikörpern (ACPA)—eine Krankheitsvariante?. Nieren und Hochdruck 1990; 19: 371
   Google Scholar
• Bach D, Hauser K, Grabensee B. Intensivmedizinische Komplikationen bei rapid progressiver Glomerulonephritis. Intensiv Med 1991; 28: 99–104
   Google Scholar
• Falk R J, Hogan S, Carey T S, Jenette J C. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Int Med 1990; 113: 656–663
   PubMed Web of Science ®Google Scholar
• Mota-Hernandez F, Briseno-Mondragon E, Gordillo-Pantagua G. Glomerular lesions and final outcome in children with glomerulonephritis of acute onset. Nephron 1976; 16: 272
   PubMedGoogle Scholar
• Kunis C L, Kiss B, Williams G, DÁgati V, Appel G B. Intravenous “pulse” cyclophosphamide therapy of crescentic glomerulonephritis. Clin Nephrol 1992; 37: 2–7
   Google Scholar
• Pernis A, D'Ágati V, Estes D, Pirani C L, Appel G B. Pulse cytoxan therapy of severe lupus nephritis. Kidney Int 1989; 35: 211
   Google Scholar
• Pusey C D, Rees A J, Evans D J, Peters D K, Lockwood C M. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40: 757–763
   PubMed Web of Science ®Google Scholar
• Pusey C D, Lockwood C M, Peters D K. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to the glomerular basement membrane. Int J Artif Org 1983; 6: 15–18
   PubMedGoogle Scholar
• Savage C OS, Pusey C D, Bowman C, Rees A J, Lockwood C M. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–1984. Br Med J 1986; 292: 301–304
   PubMedGoogle Scholar
• Cameron J S. New horizons in renal vasculitis. Klin Wochenschrift 1991; 69: 536–551
   PubMedGoogle Scholar
• Kincaid-Smith P, D'Apice A JF. Plasmapheresis in rapidly progressive glomerulonephritis. Am J Med 1978; 65: 564
   PubMed Web of Science ®Google Scholar
• Koretz S H, Feigenbaum P A, Ran J W. Long-term follow up of Wegener's granulomatosis patients treated with cytotoxic agents plus steroids. Arthr Rheum 1980; 23: 706–707
   Google Scholar
• Nossent J C, Henzen-Logmans S C, Vroom T M, Huysen V, Berden J HM, Swaak A JG. Relation between serological data at the time of biopsy and renal histology in lupus nephritis. Rheum Int 1991; 11: 77–82
   PubMedGoogle Scholar
• Gans R OB, Kuizinga M C, Goldschmeding R, Assmann K, Huysmans F, Gerlag P, Donker A, Hoorntje S. Clinical features and outcome in patients with glomerulonephritis and anti-neutrophil cytoplasmatic autoantibodies. Nephron 1993; 64: 182–188
   PubMed Web of Science ®Google Scholar